Clinical Trial Update: Avatrombopaq In Patients With Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial update for avatrombopag in patients with cirrhosis and thrombocytopenia, focusing on safety and efficacy in reducing procedural bleeding risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Thrombocytopenia; Drugs, Cirrhosis, Liver | Phase 4 | Status: UNKNOWN